Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-01-02 @ 3:39 AM
Study NCT ID:
NCT04546256
Status:
COMPLETED
Last Update Posted:
2021-03-09
First Post:
2020-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers
Sponsor:
Respirent Pharmaceuticals Co Ltd.
Organization: